BETAMETHASONE VALERATE Drug Patent Profile
✉ Email this page to a colleague
When do Betamethasone Valerate patents expire, and when can generic versions of Betamethasone Valerate launch?
Betamethasone Valerate is a drug marketed by Novast Labs, Padagis Israel, Taro, Xiromed, Fougera Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Anima, Teva Pharms, and Actavis Mid Atlantic. and is included in nineteen NDAs.
The generic ingredient in BETAMETHASONE VALERATE is betamethasone valerate. There are sixty-six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Betamethasone Valerate
A generic version of BETAMETHASONE VALERATE was approved as betamethasone valerate by FOUGERA PHARMS INC on August 31st, 1983.
Summary for BETAMETHASONE VALERATE
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 19 |
Finished Product Suppliers / Packagers: | 10 |
Raw Ingredient (Bulk) Api Vendors: | 64 |
Clinical Trials: | 16 |
Patent Applications: | 4,971 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for BETAMETHASONE VALERATE |
What excipients (inactive ingredients) are in BETAMETHASONE VALERATE? | BETAMETHASONE VALERATE excipients list |
DailyMed Link: | BETAMETHASONE VALERATE at DailyMed |
Recent Clinical Trials for BETAMETHASONE VALERATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assiut University | Phase 4 |
John Harris | Phase 2/Phase 3 |
Cairo University | Phase 4 |
Pharmacology for BETAMETHASONE VALERATE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for BETAMETHASONE VALERATE
Anatomical Therapeutic Chemical (ATC) Classes for BETAMETHASONE VALERATE
Paragraph IV (Patent) Challenges for BETAMETHASONE VALERATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
LUXIQ | Foam | betamethasone valerate | 0.12% | 020934 | 1 | 2007-08-10 |
US Patents and Regulatory Information for BETAMETHASONE VALERATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novast Labs | BETAMETHASONE VALERATE | betamethasone valerate | AEROSOL, FOAM;TOPICAL | 207144-001 | May 24, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmaderm | BETAMETHASONE VALERATE | betamethasone valerate | OINTMENT;TOPICAL | 018864-001 | Aug 31, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmaderm | BETAMETHASONE VALERATE | betamethasone valerate | CREAM;TOPICAL | 018860-002 | Aug 31, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Xiromed | BETAMETHASONE VALERATE | betamethasone valerate | AEROSOL, FOAM;TOPICAL | 210639-001 | Apr 18, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pharmaderm | BETAMETHASONE VALERATE | betamethasone valerate | LOTION;TOPICAL | 018870-001 | Aug 31, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |